Press release
Asia-Pacific Gene Therapy Industry Analysis, Growth, Development and Demand Forecast to 2030
The Asia-Pacific (APAC) gene therapy market revenue stood at $349.1 million in 2020, and it is predicted to rise to $6,931.5 million by 2030. The market will also exhibit a CAGR of 36.8% between 2021 and 2030, as per the estimates of the market research firm, P&S Intelligence. The factors driving the market expansion are the surging gene therapy activities, rising incidence of chronic diseases, and increasing number of clinical trials being conducted with positive results across the region.
The positive results of the recently conducted gene therapy clinical trials and studies are encouraging biopharmaceutical companies to focus heavily on penetrating the gene therapy market. For example, the positive results of the interim Phase I/II clinical trials, that helped determine the dose to be administered in the patients diagnosed with X-linked retinitis pigmentosa (XLRP) because of mutations in the RPGR gene, were announced by the X-Applied Genetic Technologies Corporation (AGTC) in May 2020.
Browse full report at: https://www.psmarketresearch.com/market-analysis/asia-pacific-gene-therapy-market
As per the data, the company's engineered RPGR constructs and proprietary adeno-associated viruses (AAV) vector were well tolerated and had various beneficial effects of the disease markers in a canine model of XLRP. Additionally, the treated patients showed massive improvements in their visual functions. Besides the positive results of the clinical trials, the increasing therapy development activities being carried out by various private and public research companies are also driving the expansion of the Asia-Pacific gene therapy market.
Gene therapy development processes are conducted by optimizing various vectors such as lentiviruses and retroviruses, by introducing new methods such as induced pluripotent stem cells, in combination with the current gene editing models and sometimes, even by carrying out trials in germ cells. The increasing number of these research activities are fueling the popularity of gene therapy in the APAC region. Depending on type, the APAC gene therapy market is divided into ex-vivo and in-vivo categories.
Between these, the in-vivo category held the larger share in the market between 2015 and 2020, primarily due to the high efficacy and less difficulty associated with this gene therapy method. When vector type is taken into consideration, the APAC gene therapy market is classified into herpes simplex virus (HSV), lentivirus, non-viral, and adenovirus categories. Out of these, the adenovirus category is predicted to exhibit the fastest growth in the market in the coming years.
Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/asia-pacific-gene-therapy-market/report-sample
The APAC gene therapy market is expected to exhibit the highest growth rate in China in the upcoming years. This is attributed to the increasing strategic development activities being announced by the key players and the growing prevalence of rare diseases and cancer in the country. As per an article published in the South China Morning Post in April 2019, around 20 million people are diagnosed with rare diseases in mainland China.
Therefore, the market will boom in the years to come, primarily because of the rising incidence of various chronic and rare diseases and cancer and the surging gene therapy research and development activities being carried out by various private and public companies in the APAC region.
Browse more reports:
Gene Therapy Market - https://www.psmarketresearch.com/press-release/gene-therapy-market
Radiotherapy Market - https://www.psmarketresearch.com/press-release/radiotherapy-market
Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com
About P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
The positive results of the recently conducted gene therapy clinical trials and studies are encouraging biopharmaceutical companies to focus heavily on penetrating the gene therapy market. For example, the positive results of the interim Phase I/II clinical trials, that helped determine the dose to be administered in the patients diagnosed with X-linked retinitis pigmentosa (XLRP) because of mutations in the RPGR gene, were announced by the X-Applied Genetic Technologies Corporation (AGTC) in May 2020.
Browse full report at: https://www.psmarketresearch.com/market-analysis/asia-pacific-gene-therapy-market
As per the data, the company's engineered RPGR constructs and proprietary adeno-associated viruses (AAV) vector were well tolerated and had various beneficial effects of the disease markers in a canine model of XLRP. Additionally, the treated patients showed massive improvements in their visual functions. Besides the positive results of the clinical trials, the increasing therapy development activities being carried out by various private and public research companies are also driving the expansion of the Asia-Pacific gene therapy market.
Gene therapy development processes are conducted by optimizing various vectors such as lentiviruses and retroviruses, by introducing new methods such as induced pluripotent stem cells, in combination with the current gene editing models and sometimes, even by carrying out trials in germ cells. The increasing number of these research activities are fueling the popularity of gene therapy in the APAC region. Depending on type, the APAC gene therapy market is divided into ex-vivo and in-vivo categories.
Between these, the in-vivo category held the larger share in the market between 2015 and 2020, primarily due to the high efficacy and less difficulty associated with this gene therapy method. When vector type is taken into consideration, the APAC gene therapy market is classified into herpes simplex virus (HSV), lentivirus, non-viral, and adenovirus categories. Out of these, the adenovirus category is predicted to exhibit the fastest growth in the market in the coming years.
Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/asia-pacific-gene-therapy-market/report-sample
The APAC gene therapy market is expected to exhibit the highest growth rate in China in the upcoming years. This is attributed to the increasing strategic development activities being announced by the key players and the growing prevalence of rare diseases and cancer in the country. As per an article published in the South China Morning Post in April 2019, around 20 million people are diagnosed with rare diseases in mainland China.
Therefore, the market will boom in the years to come, primarily because of the rising incidence of various chronic and rare diseases and cancer and the surging gene therapy research and development activities being carried out by various private and public companies in the APAC region.
Browse more reports:
Gene Therapy Market - https://www.psmarketresearch.com/press-release/gene-therapy-market
Radiotherapy Market - https://www.psmarketresearch.com/press-release/radiotherapy-market
Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com
About P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
